Literature DB >> 18768934

Chondroitin-4-sulfation negatively regulates axonal guidance and growth.

Hang Wang1, Yasuhiro Katagiri, Thomas E McCann, Edward Unsworth, Paul Goldsmith, Zu-Xi Yu, Fei Tan, Lizzie Santiago, Edward M Mills, Yu Wang, Aviva J Symes, Herbert M Geller.   

Abstract

Glycosaminoglycan (GAG) side chains endow extracellular matrix proteoglycans with diversity and complexity based upon the length, composition and charge distribution of the polysaccharide chain. Using cultured primary neurons, we show that specific sulfation in the GAG chains of chondroitin sulfate mediates neuronal guidance cues and axonal growth inhibition. Chondroitin-4-sulfate (CS-A), but not chondroitin-6-sulfate (CS-C), exhibits a strong negative guidance cue to mouse cerebellar granule neurons. Enzymatic and gene-based manipulations of 4-sulfation in the GAG side chains alter their ability to direct growing axons. Furthermore, 4-sulfated chondroitin sulfate GAG chains are rapidly and significantly increased in regions that do not support axonal regeneration proximal to spinal cord lesions in mice. Thus, our findings show that specific sulfation along the carbohydrate backbone carries instructions to regulate neuronal function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768934      PMCID: PMC2562295          DOI: 10.1242/jcs.032649

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  49 in total

Review 1.  Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation.

Authors:  Kristen R Taylor; Richard L Gallo
Journal:  FASEB J       Date:  2006-01       Impact factor: 5.191

2.  Axon regeneration through scars and into sites of chronic spinal cord injury.

Authors:  Paul Lu; Leonard L Jones; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2006-10-02       Impact factor: 5.330

3.  Smad3 null mice display more rapid wound closure and reduced scar formation after a stab wound to the cerebral cortex.

Authors:  Yu Wang; Helina Moges; Yasmin Bharucha; Aviva Symes
Journal:  Exp Neurol       Date:  2006-09-22       Impact factor: 5.330

4.  Profiling the sulfation specificities of glycosaminoglycan interactions with growth factors and chemotactic proteins using microarrays.

Authors:  Eric L Shipp; Linda C Hsieh-Wilson
Journal:  Chem Biol       Date:  2007-02

5.  Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes.

Authors:  George M Smith; Celia Strunz
Journal:  Glia       Date:  2005-11-15       Impact factor: 7.452

6.  Sulfation patterns of glycosaminoglycans encode molecular recognition and activity.

Authors:  Cristal I Gama; Sarah E Tully; Naoki Sotogaku; Peter M Clark; Manish Rawat; Nagarajan Vaidehi; William A Goddard; Akinori Nishi; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2006-07-30       Impact factor: 15.040

Review 7.  The role of heparan sulphate in inflammation.

Authors:  Christopher R Parish
Journal:  Nat Rev Immunol       Date:  2006-08-18       Impact factor: 53.106

8.  Purification and properties of bacterial chondroitinases and chondrosulfatases.

Authors:  T Yamagata; H Saito; O Habuchi; S Suzuki
Journal:  J Biol Chem       Date:  1968-04-10       Impact factor: 5.157

9.  Chondroitin sulfate/dermatan sulfate hybrid chains in the development of cerebellum. Spatiotemporal regulation of the expression of critical disulfated disaccharides by specific sulfotransferases.

Authors:  Chie Mitsunaga; Tadahisa Mikami; Shuji Mizumoto; Junko Fukuda; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2006-05-15       Impact factor: 5.157

Review 10.  Heparan sulphate proteoglycans fine-tune mammalian physiology.

Authors:  Joseph R Bishop; Manuela Schuksz; Jeffrey D Esko
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

View more
  110 in total

1.  An in vitro model of reactive astrogliosis and its effect on neuronal growth.

Authors:  Panpan Yu; Hang Wang; Yasuhiro Katagiri; Herbert M Geller
Journal:  Methods Mol Biol       Date:  2012

2.  The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Authors:  Andreas R Janecke; Ben Li; Manfred Boehm; Birgit Krabichler; Marianne Rohrbach; Thomas Müller; Irene Fuchs; Gretchen Golas; Yasuhiro Katagiri; Shira G Ziegler; William A Gahl; Yael Wilnai; Nicoletta Zoppi; Herbert M Geller; Cecilia Giunta; Anne Slavotinek; Beat Steinmann
Journal:  Am J Med Genet A       Date:  2015-09-16       Impact factor: 2.802

3.  Repair, protection and regeneration of spinal cord injury.

Authors: 
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

4.  Sugar-dependent modulation of neuronal development, regeneration, and plasticity by chondroitin sulfate proteoglycans.

Authors:  Gregory M Miller; Linda C Hsieh-Wilson
Journal:  Exp Neurol       Date:  2015-08-24       Impact factor: 5.330

5.  Ex vivo assessment of mouse cervical remodeling through pregnancy via 23Na MRS.

Authors:  Xiang Xu; Yucel Akgul; Mala Mahendroo; Alexej Jerschow
Journal:  NMR Biomed       Date:  2010-10       Impact factor: 4.044

6.  Phospholipid phosphatase related 1 (PLPPR1) increases cell adhesion through modulation of Rac1 activity.

Authors:  Sharada Tilve; Chinyere Agbaegbu Iweka; Jonathan Bao; Natalie Hawken; Caitlin P Mencio; Herbert M Geller
Journal:  Exp Cell Res       Date:  2020-02-14       Impact factor: 3.905

7.  Comparative Analysis of the Expression of Chondroitin Sulfate Subtypes and Their Inhibitory Effect on Axonal Growth in the Embryonic, Adult, and Injured Rat Brains.

Authors:  Moon Hang Kim; So Ra Park; Byung Hyune Choi
Journal:  Tissue Eng Regen Med       Date:  2020-09-16       Impact factor: 4.169

8.  Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro.

Authors:  Justin A Beller; Brandon Kulengowski; Edward M Kobraei; Gabrielle Curinga; Christopher M Calulot; Azita Bahrami; Thomas M Hering; Diane M Snow
Journal:  Exp Neurol       Date:  2013-03-01       Impact factor: 5.330

9.  KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.

Authors:  Mengni Yi; Panpan Yu; Qin Lu; Herbert M Geller; Zhihua Yu; Hongzhuan Chen
Journal:  Mol Cell Neurosci       Date:  2016-08-24       Impact factor: 4.314

10.  New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.

Authors:  Rebecca Robinson; James P Bertram; Jill L Reiter; Erin B Lavik
Journal:  J Microencapsul       Date:  2010-05       Impact factor: 3.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.